TABLE 2a.
Measures | Trial period | Follow‐up | ||||||
---|---|---|---|---|---|---|---|---|
T0 | T1 | T2 | T3 | T4 | T5 c | T6 c | ||
0 weeks | 12 weeks | 26 weeks | 52 weeks | 104 weeks | 156 weeks | 208 weeks | ||
General characteristics | X | |||||||
Primary outcome | X | X | X | X | X | |||
Secondary outcomes | ||||||||
(a) Function | X | X | X | X | X a | X a | ||
(b) Quality of life | X | X | X | X | X | X | ||
(c) Health care usage and costs | X | X | X | X | X | X | X | |
(d) Perceived effect and satisfaction with treatment | X b | X b | X b | X b |
The 6MWT will not be measured at T5 and T6.
In control group only if physical therapy has been used.
Or end of study for participants included after 12 months after start of the study.